Sandrock Alfred

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
3.0
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sandrock Alfred's trades of Voyager Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
7.46
Quantity 13,033
Value US$97,207
US Biogen Inc (BIIB)
Transaction date
Planned sale
Price
440.00
Quantity 7,672 -43.0%
Value US$3,375,680
US Biogen Inc (BIIB)
Transaction date
Planned sale
Price
350.00
Quantity 1,500 -10.3%
Value US$525,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-03 2026-04-02
S Sale
38,295 -46.2%
284.74
US$2,093,027 		38,295 -46.2% 284.74 US$2,093,027
2026-04-02 2026-04-02
PrS Proposed sale
74,324
212.73
US$3,514,194 		74,324 212.73 US$3,514,194
2026-02-26 2026-02-24
S Sale
78,162 -24.9%
279.50
US$979,257 		78,162 -24.9% 279.50 US$979,257
2026-02-24 2026-02-24
PrS Proposed sale
14,197
3.79
US$53,852 		14,197 3.79 US$53,852
2026-02-20 2026-02-18
S Sale
11,732 -2.3%
3.41
US$40,006 		11,732 -2.3% 3.41 US$40,006
2026-02-18 2026-02-18
PrS Proposed sale
11,732
3.41
US$40,039 		11,732 3.41 US$40,039
2026-02-11 2026-02-10
S Sale
12,192 -2.3%
3.78
US$46,086 		12,192 -2.3% 3.78 US$46,086
2026-02-10 2026-02-10
PrS Proposed sale
12,192
3.78
US$46,093 		12,192 3.78 US$46,093
2025-04-04 2025-04-02
S Sale
10,885 -2.5%
3.43
US$37,336 		10,885 -2.5% 3.43 US$37,336
2025-04-02 2025-04-02
PrS Proposed sale
10,885
3.43
US$37,369 		10,885 3.43 US$37,369
2025-02-24 2025-02-20
S Sale
11,702 -3.8%
4.24
US$49,616 		11,702 -3.8% 4.24 US$49,616
2025-02-20 2025-02-20
PrS Proposed sale
11,702
4.24
US$49,666 		11,702 4.24 US$49,666
2025-02-12 2025-02-11
PlS Planned sale
16,644 -5.1%
4.45
US$74,066 		16,644 -5.1% 4.45 US$74,066
2025-02-11 2025-02-11
PrS Proposed sale
16,644
4.45
US$74,046 		16,644 4.45 US$74,046
2024-04-03 2024-04-02
S Sale
12,115 -3.6%
9.86
US$119,454 		12,115 -3.6% 9.86 US$119,454
2024-04-02 2024-04-02
PrS Proposed sale
12,115
9.86
US$119,507 		12,115 9.86 US$119,507
2024-02-22 2024-02-21
S Sale
13,033 -3.7%
7.46
US$97,226 		13,033 -3.7% 7.46 US$97,226
2024-02-21 2024-02-21
PrS Proposed sale
13,033
7.46
US$97,207 		13,033 7.46 US$97,207
2023-04-05 2023-04-03
S Sale
7,437 -3.3%
7.83
US$58,232 		7,437 -3.3% 7.83 US$58,232
2021-06-09 2021-06-07
US Biogen Inc (BIIB)
PlS Planned sale
7,672 -43.0%
440.00
US$3,375,680 		7,672 -43.0% 440.00 US$3,375,680
2020-11-06 2020-11-04
US Biogen Inc (BIIB)
PlS Planned sale
1,500 -10.3%
350.00
US$525,000 		1,500 -10.3% 350.00 US$525,000